Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.

Cancer research - 15 Dec 2000

Mustjoki S, Sidenius N, Sier C F, Blasi F, Elonen E, Alitalo R, Vaheri A

Abstract excerpt

The importance of plasminogen activation, mediated by urokinase (uPA) and its receptor (uPAR), is well established in many physiologica and pathological processes, such as in cell migration and tumor-cell invasion. Recently, additional functions have been described for uPA and uPAR, particularly in cell adhesion and chemotaxis. The amounts of uPA and uPAR in various tumor types and in the plasma/serum samples of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Creatinine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid

Share to Leukocytes

Share to Neoplastic Cells, Circulating

Share to Precipitin Tests

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Receptors, Urokinase Plasminogen Activator

Source

Identifiers

PMID: 11156421

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Soluble urokinase receptor levels correlate with number of circulating tumor cells in acute myeloid leukemia and decrease rapidly during chemotherapy.PMID 11156421Read ↗

The Urokinase Plasminogen Activator System in Human Cancers: An Overview of Its Prognostic and Predictive RoleSemantic proximity Read ↗

The role and regulation of urokinase-type plasminogen activator receptor gene expression in cancer invasion and metastasisSemantic proximity Read ↗

Characterisation of urokinase plasminogen activator receptor variants in human airway and peripheral cellsSemantic proximity Read ↗

Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors.Semantic proximity Read ↗

Molecular regulation of urokinase-receptor gene expression as one potential concept for molecular staging and therapy.Semantic proximity Read ↗

High tumor tissue concentration of urokinase plasminogen activator receptor is associated with good prognosis in patients with ovarian cancer.Semantic proximity Read ↗

The role of the plasminogen activation system in angiogenesis and metastasis.Semantic proximity Read ↗

Diversity and functional evolution of the plasminogen activator system.Semantic proximity Read ↗

Urokinase-Receptor (u-PAR)–An Essential Player in Multiple Games of Cancer: A Review on Its Role in Tumor Progression, Invasion, Metastasis, Proliferation/dormancy, Clinical Outcome and Minimal Residual DiseaseSemantic proximity Read ↗

uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages.Semantic proximity Read ↗

Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging ProbesSemantic proximity Read ↗

An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.